Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Duda

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Parkinsonism & Related Disorders|June 27, 2006
Frequency and correlates of co-morbid psychosis and depression in Parkinson's diseaseDaniel Weintraub, Knashawn H Morales, John E Duda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal studyFatma Nabli, Samia Ben Sassi, Rim Amouri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 24, 2014
The spectrum of cognitive impairment in Lewy body diseasesJennifer G Goldman, Caroline Williams-Gray, Roger A Barker, et al.
Parkinsonism & Related Disorders|May 6, 2015
Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's diseaseAmy M Hellman, Shital P Shah, Stephanie M Pawlowski, et al.
Parkinsonism & Related Disorders|April 19, 2014
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced ParkinsonismJames F Morley, Stephanie M Pawlowski, Adhithi Kesari, et al.
Journal of Rehabilitation Research and Development|June 14, 2013
Laser light visual cueing for freezing of gait in Parkinson disease: A pilot study with male participantsLisette Bunting-Perry, Meredith Spindler, Keith M Robinson, et al.
Movement Disorders Clinical Practice|October 27, 2018
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced ParkinsonismJames F Morley, Gang Cheng, Jacob G Dubroff, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 12, 2006
Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage studyDaniel Weintraub, Donna Taraborelli, Knashawn H Morales, et al.
Annals of Neurology|September 5, 2002
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesJohn E Duda, Benoit I Giasson, Meghann E Mabon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 26, 2011
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJames F Morley, Daniel Weintraub, Eugenia Mamikonyan, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Parkinsonism & Related Disorders|June 27, 2006
Frequency and correlates of co-morbid psychosis and depression in Parkinson's diseaseDaniel Weintraub, Knashawn H Morales, John E Duda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal studyFatma Nabli, Samia Ben Sassi, Rim Amouri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 24, 2014
The spectrum of cognitive impairment in Lewy body diseasesJennifer G Goldman, Caroline Williams-Gray, Roger A Barker, et al.
Parkinsonism & Related Disorders|May 6, 2015
Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's diseaseAmy M Hellman, Shital P Shah, Stephanie M Pawlowski, et al.
Parkinsonism & Related Disorders|April 19, 2014
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced ParkinsonismJames F Morley, Stephanie M Pawlowski, Adhithi Kesari, et al.
Journal of Rehabilitation Research and Development|June 14, 2013
Laser light visual cueing for freezing of gait in Parkinson disease: A pilot study with male participantsLisette Bunting-Perry, Meredith Spindler, Keith M Robinson, et al.
Movement Disorders Clinical Practice|October 27, 2018
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced ParkinsonismJames F Morley, Gang Cheng, Jacob G Dubroff, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 12, 2006
Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage studyDaniel Weintraub, Donna Taraborelli, Knashawn H Morales, et al.
Annals of Neurology|September 5, 2002
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesJohn E Duda, Benoit I Giasson, Meghann E Mabon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 26, 2011
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJames F Morley, Daniel Weintraub, Eugenia Mamikonyan, et al.
Pageof 13